Vanta Bioscience Limited (BOM:540729)

India · Delayed Price · Currency is INR

15.15

+0.25 (1.68%)

At close: Mar 30, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
Full Service Preclinical Contract Research Organization	19.64M	97.23M	62.76M	100.18M	100.51M
Full Service Preclinical Contract Research Organization Growth	-79.80%	54.92%	-37.36%	-0.33%	-28.94%
Total	19.64M	97.23M	62.76M	100.18M	100.51M
Total Growth	-79.80%	54.92%	-37.36%	-0.33%	-28.94%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018
India	4.91M	19.91M	41.23M	23.79M	14.39M
India Growth	-75.34%	-51.71%	73.29%	65.35%	-44.27%
Export	14.73M	77.32M	21.53M	53.47M	67.23M
Export Growth	-80.95%	259.11%	-59.73%	-20.47%	-2.00%
Unallocated	-	-	-	19.62M	18.77M
Unallocated Growth	-	-	-	4.53%	-60.08%
Total	19.64M	97.23M	62.76M	96.87M	100.38M
Total Growth	-79.80%	54.92%	-35.22%	-3.50%	-29.02%

Source: S&P Global Market Intelligence.